Plus Therapeutics Inc (NASDAQ:PSTV)

2.32
Delayed Data
As of Jan 28
 -0.01 / -0.43%
Today’s Change
1.78
Today|||52-Week Range
24.45
-3.33%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Plus Therapeutics Inc have a median target of 7.50, with a high estimate of 7.50 and a low estimate of 7.50. The median estimate represents a +223.28% increase from the last price of 2.32.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Buy stock in Plus Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$5.72
Sales
$0.00
Reporting Date
Mar 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -18,966.67%
 
 
 
 
 
 
Growthannually 71.23%
 
 
 
 
 
 

Sales

Growthquarterly -100.00%
 
 
 
 
 
 
Growthannually 14.04%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.